← k3vl4r
Log inGet started →

GLMD (Galmed Pharmaceuticals Ltd) Price Forecast

AI-generated price forecast for Galmed Pharmaceuticals Ltd (GLMD) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of August 2026: K3vl4r's AI model currently reads GLMD as 2/2 bullish · strong across its horizons (2 of 2 timeframes pointing up), with a last price of 0.5670. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

0.5670

AI outlook

2/2 bullish · STRONG

Timeframes up

2 / 2

Share𝕏 Post✈ Telegram

GLMD forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour~2 days out———
4-hour~2 months out———
Daily~5 months out▲ Up+66.04%—
Weekly~1.9 years out▲ Up+606.81%—

Latest GLMD news

From the market-news feed the forecasts are read against.

  • Galmed Pharma Announces Continued Advancement Of Aramchol As Potential Disease-Modifying Therapy For Parkinson's Disease, Reporting Significant Progress In Development Of New Aramchol ODF Formulation · Benzinga · Jul 28
  • Galmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular Pipeline (NASDAQ:GLMD) · InvestorsHub · Jul 16
  • Galmed Pharmaceuticals Announces Breakthrough Development Of New Aramchol-Based Lipid Nanoparticles Formulation For Targeted Delivery To The Heart · Benzinga · Jul 16

🔒

See the full GLMD forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

GLMD forecast — frequently asked

Will GLMD go up?

K3vl4r's AI model currently reads GLMD as 2/2 bullish · STRONG — 2 of 2 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the GLMD price prediction for 2026?

K3vl4r's model projects GLMD toward $0.6251 over the next ~5 months, a +0.7% move from $0.6210. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could GLMD reach?

Over its longest horizon (~~1.9 years), the model's projected target for GLMD is $0.6587 (+6.1% vs $0.6210). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

DRTSMBRXELABAEMDARQTIDYAPSNLAPGECODXZURACINGALECAGENTWST

Will GLMD reach…?

Will GLMD reach $1.00?Will GLMD reach $2.00?Will GLMD reach $3.00?

Or see the full GLMD price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare GLMD

GLMD vs DRTSGLMD vs MBRXGLMD vs ELABGLMD vs AEMDGLMD vs ARQTGLMD vs IDYA

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordChart indicatorsToday's outlookBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.